<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2012</study_start_year><condition>Liver metastases from colorectal cancer</condition><disease>Liver Metastases From Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2624492</full_dataset_link><location>Japan</location><study_start_month>10</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>A phase II non-randomized open labeled trial for preoperative circadian chronomodulated hepatic arterial infusion (HAI) chemotherapy combined with panitumumab for liver metastases from colorectal cancer.</name><description>Interventions: Chronomodulated HAI chemotherapy group The patients of this group will receive 6 cycles of chronomodulated HAI chemotherapy with 5-FU/LV/L-OHP before hepatectomy for liver metastases from colorectal cancer 
Chronomodulated HAI chemotherapy with Panitumumab group The patients of this group will receive 6 cycles of chronomodulated HAI chemotherapy with 5-FU/LV/L-OHP and Panitumumab before hepatectomy for liver metastases from colorectal cancer
Primary outcome(s): Response rate
Study Design: Parallel Non-randomized</description><dates><creation>2012-10-15</creation></dates><accession>2624492</accession><cross_references><Japan Primary Registries Network>JPRN-UMIN000009091</Japan Primary Registries Network></cross_references></HashMap>